Design and Development of National Drug Regulatory System and Policies

Read full text Summarise with VIRAT
Authors: Puli Sriharsha, B. Thejovathi, L. Harikiran
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Regulation of drugs encompasses a variety of functions. Key functions include licensing, inspection of manufacturing facilities and distribution channels, product assessment and registration, adverse drug reaction (ADR) monitoring, QC, control of drug promotion and advertising, and control of clinical drug trials. Each of these functions targets a different aspect of pharmaceutical activity. All of these functions must act in concert for effective consumer protection. Quality of drugs available to the public is the main aim of drug regulation. If regulatory goals are to be achieved, appropriate structures must be established and appropriate activities carried out to achieve the desired goals. Comprehensive and up-to-date laws, unified but independent organization, competent human resources, freedom from political and commercial influence, adequate and sustainable financial resources, clear and transparent standards and procedures, outcome-oriented implementation and systematic monitoring and evaluation are critical components contributing to effective drug regulation.

Fields of Study & Subjects

Healthcare Regulation Pharmaceutical Quality and Counterfeiting Pharmaceutical Economics and Policy

Publication details

Journal / source
International Journal of Allied Medical Sciences and Clinical Research
Volume
14
Issue
1
Pages
121–139
Publication date
19 February 2026
Language
EN